Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 16Colorectal Neoplasms 9Liver Neoplasms 8Cholangiocarcinoma 8Recurrence 6Neoplasm Metastasis 4Klatskin Tumor 4Fibrosis 4Neoplasms 2Liver Diseases 2Hypertension, Portal 2Bile Duct Neoplasms 2Reperfusion Injury 1Rejection, Psychology 1Patient Dropouts 1PRETEXT I Hepatoblastoma 1Neuroendocrine Tumors 1Liver Diseases, Alcoholic 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Colorectal Liver Metastases 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Cholangitis, Sclerosing 1Alcoholism 1

Interventions

Gemcitabine 61Cisplatin 39Oxaliplatin 31Capecitabine 29Fluorouracil 22Leucovorin 20Irinotecan 12pembrolizumab 11130-nm albumin-bound paclitaxel 10durvalumab 9Erlotinib Hydrochloride 8Trastuzumab 7Bevacizumab 7Taxes 6Platinum 6Magnetic Resonance Spectroscopy 6Biopsy 6Albumin-Bound Paclitaxel 61,2-diaminocyclohexaneplatinum II citrate 6Specimen Handling 5Sorafenib 5Radiotherapy 5Docetaxel 5Carboplatin 5Immunohistochemistry 4trifluridine tipiracil drug combination 3dehydroftorafur 3atezolizumab 3Watchful Waiting 3Tegafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Neoplasms × Liver Transplantation × Clear all
NCT01151761 2016-07-29

Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

Stanford University

Phase 2 Terminated
2 enrolled 9 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡